Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy

OBJECTIVE: Sarcomeric gene mutation carriers without overt left ventricular hypertrophy (G+/LVH−) can harbour subclinical changes in cardiovascular structure and function that precede the development of hypertrophic cardiomyopathy (HCM). We sought to investigate if circulating biomarkers of cardiova...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Jennifer E, Shi, Ling, Day, Sharlene M, Colan, Steven D, Russell, Mark W, Towbin, Jeffrey A, Sherrid, Mark V, Canter, Charles E, Jefferies, John Lynn, Murphy, Anne, Taylor, Matthew, Mestroni, Luisa, Cirino, Allison L, Sleeper, Lynn A, Jarolim, Peter, Lopez, Begoña, Gonzalez, Arantxa, Diez, Javier, Orav, E John, Ho, Carolyn Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Heart Failure and Cardiomyopathies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687543/
https://www.ncbi.nlm.nih.gov/pubmed/29177058
http://dx.doi.org/10.1136/openhrt-2017-000615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687543/
https://www.ncbi.nlm.nih.gov/pubmed/29177058
http://dx.doi.org/10.1136/openhrt-2017-000615

Ejemplares similares